Surgery Partners (SGRY) Cost of Revenue (2014 - 2026)

Surgery Partners' Cost of Revenue history runs 13 years deep, the most recent figure standing at $220.2 million for Q1 2026.

• In Q1 2026, Cost of Revenue rose 405.05% year-over-year to $220.2 million; the TTM figure through Mar 2026 stood at $378.0 million (up 4.94% YoY), while the FY2025 annual figure was $201.4 million, down 75.22% from the prior year.
• Cost of Revenue came in at $220.2 million for Q1 2026 at Surgery Partners, up from $53.4 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $592.9 million in Q4 2022 to a low of -$374.5 million in Q4 2023.
• A 5-year average of $73.8 million and a median of $45.6 million in 2023 frame the typical range for Cost of Revenue.
• Across the five-year window, Cost of Revenue jumped 1648.97% in 2022 and plunged 163.16% in 2023, its largest moves.
• Surgery Partners' Cost of Revenue stood at $592.9 million in 2022, then slumped by 163.16% to -$374.5 million in 2023, then surged by 159.55% to $223.0 million in 2024, then tumbled by 76.05% to $53.4 million in 2025, then surged by 312.36% to $220.2 million in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $220.2 million, $53.4 million, and $49.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison